Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing
Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs
Who this might be right for
Rheumatoid Arthritis
AbbVie 197